Supportive Care with Mepilex Up for Venous Leg Ulcer

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Center for Clinical Research, Inc., Castro Valley, CAVenous Leg Ulcer+5 MoreMepilex Up - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will monitor the progress of wounds in people with venous or diabetic ulcers while they use Mepilex Up dressing to see how it helps them heal over time.

Eligible Conditions
  • Venous Leg Ulcer
  • wound
  • Skin Wound
  • Wound Leg
  • Foot Wound
  • Diabetic Foot Ulcers

Treatment Effectiveness

Study Objectives

1 Primary · 28 Secondary · Reporting Duration: A maximum total treatment period of 44 days or until healed, whichever occurs first.

Day 44
Compliance to offloading
Compliance with compression
Compression removed/changed/applied
Evaluation of Wound Quality of Life (QoL) (PRO)
For DFU: Mepilex Up ability to be comfortable to wear with offloading (PRO)
For VLU: Mepilex Up ability to be comfortable to wear with compression (PRO)
Offloading Use/Type
Edema
Primary dressing's ability to be comfortable to wear (PRO)
Status of dressing during a routine dressing change or complication
Technical Performance (Investigator/designee's evaluation)
Injury wounds
Pain
Day 44
Change in exudate amount over time
Change in exudate nature over time
Change in granulation tissue over time
Change in maceration over time
Skin
Change in sloughy tissue over time
Cleansing performed
Debridement
Evaluation of all reported adverse events and device deficiencies
Injury wounds
Percentage wound area reduction over time
Percentage wound volume reduction over time (DFUs only)
Wear time (days)
Pain
Injury wounds
Injury wounds

Trial Safety

Trial Design

1 Treatment Group

Supportive Care with Mepilex Up
1 of 1

Experimental Treatment

68 Total Participants · 1 Treatment Group

Primary Treatment: Supportive Care with Mepilex Up · No Placebo Group · N/A

Supportive Care with Mepilex Up
Device
Experimental Group · 1 Intervention: Mepilex Up · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: a maximum total treatment period of 44 days or until healed, whichever occurs first.

Who is running the clinical trial?

Molnlycke Health Care ABLead Sponsor
53 Previous Clinical Trials
14,266 Total Patients Enrolled
Hadar Lev-Tov, MD, MASPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
129 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

What is the scale of this research investigation?

"Affirmative. According to clinicaltrials.gov, this research protocol is currently recruiting participants; it was posted on October 31st 2022 and revised on November 7th of the same year. The study has room for 68 enrollees between two sites." - Anonymous Online Contributor

Unverified Answer

Does this research currently have any room for new participants?

"As per the information available on clinicaltrials.gov, this research is currently recruiting individuals to take part in the trial. This study was publicly uploaded on October 31st 2022 and has since been revised on November 7th of that year." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.